BNY Mellon Plans to Boost Quarterly Dividend by 13 Percent to $0.53

BNY Mellon Plans to Increase Quarterly Dividend

The Bank of New York Mellon Corporation (BNY) is making headlines with its recent announcement to raise the quarterly common stock dividend from $0.47 to $0.53 per share, representing a 13% increase. This intended change, anticipated to take effect in the third quarter of 2025, is contingent on the approval from the company's Board of Directors.

On June 27, 2025, the Federal Reserve released the results of its annual bank stress tests, showcasing BNY’s robust business model and its strong financial balance sheet. The results confirmed BNY's preliminary Stress Capital Buffer (SCB) requirement of 2.5%, which aligns with the regulatory floor set for financial institutions.

The SCB will remain effective from October 1, 2025, to September 30, 2026, under the currently established capital planning rules. Since the introduction of this requirement in 2020, BNY has consistently maintained its SCB at the 2.5% floor. With a proposed rulemaking from the Federal Reserve aiming to reduce SCB volatility announced on April 17, 2025, BNY does not expect any adverse effects on its requirement.

Robin Vince, Chief Executive Officer of BNY, commented on the announcement, emphasizing the significant role the bank plays in global financial markets. He stated, "BNY serves our clients with innovative and resilient platforms that enable them to grow their businesses and navigate an increasingly complex world. The results of the Federal Reserve's annual bank stress test demonstrate our strength and ability to support clients through extreme economic stress scenarios."

Vince further highlighted that the move to increase the common dividend reflects BNY's commitment to delivering value to both shareholders and clients. The bank’s strategy to operate as a platform company is proving effective, providing notable momentum moving forward.

In addition to the dividend increase, BNY continues to be authorized for share repurchase under its existing program, approved by the Board in April 2024. The specifics regarding the timing, manner, and volume of repurchases will adhere to various factors including the state of the company's capital position and the prevailing market conditions.

About BNY Mellon

BNY is a leading global financial services institution dedicated to making money work for its clients worldwide. Established over 240 years ago, BNY has forged durable partnerships that leverage its expertise to help clients achieve their ambitions. Today, the bank services over 90% of Fortune 100 companies and nearly all top 100 banks globally, facilitating access to essential capital. Furthermore, BNY supports governments in financing local projects and collaborates with over 90% of the top 100 pension plans to secure investments for millions of individuals.

As of March 31, 2025, BNY oversees a staggering $53.1 trillion in assets under custody and/or administration, along with managing $2.0 trillion in assets. The institution is recognized not only for its legacy but also for being named among Fortune's World's Most Admired Companies and Fast Company's Best Workplaces for Innovators.

For further updates and information, visit BNY's official website or follow them on LinkedIn. In this evolving investment landscape, BNY continues to harness its extensive capabilities to navigate future challenges and opportunities.

This announcement contains forward-looking statements as per the Private Securities Litigation Reform Act of 1995. These statements encapsulate various elements, including but not limited to, anticipated outcomes concerning BNY's stock repurchases and dividend declarations. These forecasts are subject to inherent unpredictability and can differ significantly from expected results due to numerous factors, including regulatory requirements and market conditions. All assertions in this announcement are valid as of the explicit date of communication, and BNY assumes no obligation to amend any statement to reflect later developments.